Advanced

Severity of pancreatitis-associated gut barrier dysfunction is reduced following treatment with the PAF inhibitor lexipafant.

Leveau, Per LU ; Wang, Xiangdong LU ; Sun, Zhengwu LU ; Börjesson, Anna LU ; Andersson, Ellen LU and Andersson, Roland LU (2005) In Biochemical Pharmacology 69(9). p.1325-1331
Please use this url to cite or link to this publication:
author
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Biochemical Pharmacology
volume
69
issue
9
pages
1325 - 1331
publisher
Elsevier
external identifiers
  • wos:000228700100004
  • pmid:15826603
  • scopus:17044378440
ISSN
0006-2952
DOI
10.1016/j.bcp.2005.01.023
language
English
LU publication?
yes
id
b4ff413f-16d5-4250-9ad3-14bb9ba7de43 (old id 136230)
alternative location
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15826603&dopt=Abstract
date added to LUP
2007-07-04 09:57:42
date last changed
2017-11-12 03:22:11
@article{b4ff413f-16d5-4250-9ad3-14bb9ba7de43,
  author       = {Leveau, Per and Wang, Xiangdong and Sun, Zhengwu and Börjesson, Anna and Andersson, Ellen and Andersson, Roland},
  issn         = {0006-2952},
  language     = {eng},
  number       = {9},
  pages        = {1325--1331},
  publisher    = {Elsevier},
  series       = {Biochemical Pharmacology},
  title        = {Severity of pancreatitis-associated gut barrier dysfunction is reduced following treatment with the PAF inhibitor lexipafant.},
  url          = {http://dx.doi.org/10.1016/j.bcp.2005.01.023},
  volume       = {69},
  year         = {2005},
}